Luxturna (voretigene neparvovec)

pCPA File Number: 21334
Negotiation Status:
Under consideration for negotiation
Indication(s):
Inherited retinal disease
Sponsor/Manufacturer:
Novartis Pharma Canada Inc.
CADTH Project Number:
SG0643-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable